Navigation Links
Fingerprints May Vanish With Cancer Drug
Date:5/27/2009

Travelers are warned of side effect that could hamper immigration checks

WEDNESDAY, May 27 (HealthDay News) -- The widely used cancer drug capecitabine can cause people to lose their fingerprints, which could lead to problems when they're trying to enter the United States, an oncologist warns.

Dr. Eng-Huat Tan, a senior consultant in medical oncology at the National Cancer Centre in Singapore, said he now advises people taking capecitabine to carry a doctor's letter when traveling.

In a letter published online Wednesday in the Annals of Oncology, Tan described the experience of a 62-year-old cancer patient taking capecitabine who was held for four hours by U.S. immigration officials because his fingerprints had vanished. The man was eventually allowed into the country.

Tan said that several other cancer patients have reported the loss of fingerprints on their blog sites and some have also said they've had problems entering the United States.

Capecitabine -- used to treat head and neck cancers, breast, stomach and colorectal cancers, among others -- can cause a side effect called hand-foot syndrome. This is a chronic inflammation of the palms of the hands or soles of the feet that can cause the skin to peel, bleed and develop ulcers or blisters, Tan said.

"This can give rise to eradication of fingerprints with time," he explained.

"In summary, patients taking long-term capecitabine may have problems with regards to fingerprint identification when they enter the United States' ports or other countries that require fingerprint identification and should be warned about this," Tan wrote.

"It is uncertain when the onset of fingerprint loss will take place in susceptible patients who are taking capecitabine," Tan said. "However, it is possible that there may be a growing number of such patients as 'Mr. S.' who may benefit from maintenance capecitabine for disseminated malignancy. These patients should prepare adequately before traveling to avert the inconvenience that 'Mr. S.' was put through."

Tan recommended that people taking capecitabine carry a letter from their oncologist.

"My patient subsequently traveled again with a letter from us, and he had fewer problems getting through" immigration, Tan said.

More information

The U.S. National Library of Medicine has more about capecitabine.



-- Robert Preidt



SOURCE: Annals of Oncology, news release, May 27, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cancer drug causes patient to lose fingerprints and be detained by US immigration
2. DNA Fingerprints Predict Brain Disorders
3. Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research
4. Berkeley Lab scientist co-leads breast cancer dream team
5. $18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research
6. New Survey Highlights Growing Concern About Risk of Infection in Cancer Patients and Emerging Antibiotic Resistance
7. Gene Mutation May Up Risks of Endometrial Cancer
8. U.S. Cancer Death Rates Continue to Fall
9. Hanes(R) Teams up with Susan G. Komen for the Cure(R) and Actress Sarah Chalke to Comfort Those Affected by Breast Cancer
10. Predicting higher risk for prostate cancer diagnosis
11. Risks Remain for Childhood Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fingerprints May Vanish With Cancer Drug
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for giving! Today, 20 creative ... National Family Partnership and the Drug Enforcement Administration as part of the National Red ... 10 winning schools who decorated their campuses with this year’s Red Ribbon Week theme: ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... they now offer a comprehensive in-house dental plan for all patients. Understanding that ... a plan that gives patients a number of perks, including discounts on many ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... Deloitte Wisconsin 75, an annual ranking and recognition of the largest closely held ... list, having ranked from 2008-2016. In addition, Standard Process was awarded the Talent ...
(Date:11/30/2016)... ... November 30, 2016 , ... Center For ... announced the opening of a new residential mental health treatment program in Chino ... issues such as severe anxiety, depression, bi-polar disorder, and other related issues. , ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... and stylish design wanted by today’s consumers at an affordable price, is now ... says the new watch is “a game changer” when it comes to the ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... bioLytical Laboratories, ein Weltführer bei schnellen Tests für ... Apothekenbundes von Kenia eingeführt. Continue Reading ... ... Test! (PRNewsFoto/bioLytical Laboratories) ... http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical wurde durch die ...
(Date:12/2/2016)... , December 2, 2016 Orthopedic Implants ... Support) is Expected to Gain a Significant Market Share Owing ... Ailments  ... According to a new ... Medical Implants Sterile Packaging: Clamshell Product Type Segment Projected to ...
(Date:12/2/2016)... December 2, 2016 On Thursday, the ... in red, while the Dow Jones Industrial Average managed to ... of US markets, which prompted Stock-callers this morning to look ... (NASDAQ: NUVA ), Smith & Nephew PLC (NYSE: ... NXTM ), and Cesca Therapeutics Inc. (NASDAQ: KOOL ...
Breaking Medicine Technology: